Perspective view of allogeneic IgG tumor immunotherapy.

Authors:
Liu Y; Huang Y; Cui HW; Wang Y; Ma Z and 4 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-024-03290-9

PMCID:
PMC10924995

PMID:
38461238

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through th…
Zhang Y; Li W; Yang Y and 8 more (2024) - Transparency Score: 3/6
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.
Hong L; Tang X; Han J and 3 more (2024) - Transparency Score: 3/6
ACADL-YAP axis activity in non-small cell lung cancer carcinogenicity.
Chen K; Hong C; Kong W and 8 more (2024) - Transparency Score: 3/6
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses …
Ren H; Liu C; Zhang C and 7 more (2024) - Transparency Score: 3/6
A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immu…
Tang Y; Wang T; Li Q and 1 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The present study was supported by the National Natural Science Foundation of China (81872412, 81602303), the Basic and Applied Basic Research Funding of Guangdong Province, China (2023A1515010798), and the Open Projects of the Key Laboratory of Human Genetic Diseases Research of Inner Mongolia, China (YC202201)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025